Breast cancer (advanced or metastatic) - lapatinib: appeal announcement
The Institute have received an appeal from GlaxoSmithKline.
The Appeal hearing took place at NICE, MidCity Place 71 High Holborn, London WC1V 6NA - Tuesday 17 August at 10am
The Institute awaits the decision of the Appeal panel.
This page was last updated: 19 February 2011